BRNS
COM:BARINTHUSBIO
Barinthus Biotherapeutics plc
- Stock
Last Close
0.98
22/11 21:00
Market Cap
55.90M
Beta: -
Volume Today
142.16K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
average inventory | ||||||
average payables | 4.28M - | 3.54M 17.18% | 3.08M 12.97% | 2.67M 13.26% | ||
average receivables | 4.26M - | 8.16M 91.71% | 14.90M 82.63% | 9.05M 39.30% | ||
book value per share | -782.92 - | 9.74 101.24% | 6.52 33.03% | 4.87K 74,519.25% | ||
capex per share | -6.15 - | -0.04 99.28% | -0.16 272.34% | |||
capex to depreciation | -0.37 - | -1.41 280.69% | -1.90 35.14% | -1.42 25.41% | ||
capex to operating cash flow | 0.01 - | 0.03 288.33% | 0.04 32.38% | 0.43 1,109.31% | ||
capex to revenue | -0.02 - | -0.06 225.47% | -4.28 6,935.89% | -0.14 96.79% | ||
cash per share | 908.07 - | 8.27 99.09% | 5.22 36.87% | 3.70K 70,830.39% | ||
days of inventory on hand | ||||||
days payables outstanding | -2.58B - | |||||
days sales outstanding | 207.52 - | 348.72 68.04% | 15.96K 4,475.70% | 147.73 99.07% | ||
debt to assets | 0.09 - | 0.92 880.23% | 0.03 97.19% | 0.03 26.20% | 0.06 86.31% | |
debt to equity | -0.08 - | -1.24 1,469.30% | 0.03 102.30% | 0.04 26.09% | 0.07 92.34% | |
dividend yield | ||||||
earnings yield | -26.36 - | -0.18 99.33% | 0.06 134.52% | -517.83 848,599.39% | ||
enterprise value | -9.65M - | 3.77M 139.05% | 80.85M 2,044.79% | -98.08M 221.30% | -128.97M 31.50% | |
enterprise value over ebitda | 0.38 - | -0.23 160.10% | -2.01 779.39% | -18.89 841.17% | 1.54 108.14% | |
ev to operating cash flow | 0.51 - | -0.34 166.42% | -2.48 625.92% | 6.80 373.88% | 2.53 62.74% | |
ev to sales | -1.40 - | 0.78 155.67% | 301.70 38,482.22% | -2.19 100.73% | -160.81 7,229.65% | |
free cash flow per share | -237.61 - | -1.30 99.45% | -0.55 57.61% | -1.33K 240,142.27% | ||
free cash flow yield | -16.85 - | -0.12 99.30% | -0.23 100.43% | -359.53 152,899.82% | ||
graham net net | -857.52 - | 7.52 100.88% | 4.86 35.39% | 2.98K 61,343.54% | ||
graham number | 2.56K - | 20.74 99.19% | 4.59 77.89% | 14.46K 315,204.71% | ||
income quality | 0.90 - | 0.61 31.76% | 0.64 3.66% | -2.71 525.44% | ||
intangibles to total assets | 0 - | 0 | 0.16 Infinity% | 0.15 4.56% | 0.17 16.13% | |
interest coverage | -193.33 - | -5.57 97.12% | -16.95 204.39% | -212.68 1,154.82% | 3.00K 1,509.10% | |
interest debt per share | 1.05K - | 0.38 99.96% | 0.24 38.20% | 337.31 142,804.72% | ||
inventory turnover | ||||||
invested capital | -0.08 - | -1.24 1,469.30% | 0.03 102.30% | 0.04 26.09% | 0.07 92.34% | |
market cap | 671.81K - | 287.69M 42,722.69% | 87.53M 69.57% | 141.64K 99.84% | ||
net current asset value | -24.87M - | -39.68M 59.52% | 198.61M 600.57% | 186.04M 6.33% | 129.39M 30.45% | |
net debt to ebitda | 0.38 - | -0.19 149.39% | 5.13 2,837.38% | -35.75 796.28% | 1.54 104.30% | |
net income per share | -371.62 - | -1.96 99.47% | 0.14 107.30% | -1.91K 1,332,424.58% | ||
operating cash flow per share | -231.46 - | -1.26 99.46% | -0.39 69.21% | -1.33K 342,325.56% | ||
payables turnover | -0.00 - | |||||
receivables turnover | 1.76 - | 1.05 40.49% | 0.02 97.81% | 2.47 10,701.17% | ||
research and ddevelopement to revenue | 4.36 - | 2.30 47.15% | 61.08 2,551.03% | 0.92 98.49% | 55.95 5,984.29% | |
return on tangible assets | -1.09 - | -0.35 68.03% | -0.21 38.50% | 0.02 110.82% | -0.41 1,880.14% | |
revenue per share | 101.18 - | 0.01 99.99% | 1.20 11,495.86% | 20.89 1,640.88% | ||
roe | 0.93 - | 0.47 48.82% | -0.20 142.50% | 0.02 110.90% | -0.39 1,885.50% | |
roic | 1.24 - | -1.88 251.11% | -0.17 90.97% | -0.10 42.75% | -0.38 289.26% | |
sales general and administrative to revenue | 2.17 - | 93.72 4,211.48% | 0.14 99.85% | 49.68 34,632.08% | ||
shareholders equity per share | -782.92 - | 9.74 101.24% | 6.52 33.03% | 4.87K 74,519.25% | ||
stock based compensation to revenue | 0.75 - | 61.52 8,081.56% | 0.22 99.64% | |||
tangible asset value | -22.08M - | -36.91M 67.18% | 208.50M 664.86% | 202.72M 2.77% | 149.68M 26.17% | |
tangible book value per share | -774.71 - | 8.05 101.04% | 5.44 32.41% | 3.90K 71,545.10% | ||
working capital | 10.50M - | 40.26M 283.52% | 215.61M 435.54% | 200.80M 6.87% | 144.31M 28.13% |
All numbers in USD (except ratios and percentages)